Modeling the impact of prostate cancer early diagnosis on managed care plans

Clin Lab Manage Rev. 1997 Mar-Apr;11(2):107-12.

Abstract

Efforts to improve decisions about the appropriate use of new and existing technologies have prompted the development of technology assessment committees and advisory panels within managed care plans. As part of this development, plans are using a variety of sophisticated tools to aid their decision making. One such tool is the actuarial model, a method of quantitatively estimating the risk associated with providing care to specified populations.

MeSH terms

  • Actuarial Analysis*
  • Costs and Cost Analysis
  • Critical Pathways*
  • Decision Making
  • Humans
  • Male
  • Managed Care Programs / economics
  • Managed Care Programs / standards*
  • Models, Theoretical
  • Prostate-Specific Antigen*
  • Prostatic Neoplasms / diagnosis*
  • Technology Assessment, Biomedical*
  • United States

Substances

  • Prostate-Specific Antigen